CN105193993A - 一种具有降血脂功效的中药组合物及其制备方法与用途 - Google Patents
一种具有降血脂功效的中药组合物及其制备方法与用途 Download PDFInfo
- Publication number
- CN105193993A CN105193993A CN201510743094.6A CN201510743094A CN105193993A CN 105193993 A CN105193993 A CN 105193993A CN 201510743094 A CN201510743094 A CN 201510743094A CN 105193993 A CN105193993 A CN 105193993A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- preparation
- parts
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 100
- 239000000203 mixture Substances 0.000 title claims abstract description 81
- 210000004369 blood Anatomy 0.000 title claims abstract description 48
- 239000008280 blood Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 150000002632 lipids Chemical class 0.000 title abstract description 20
- 230000009467 reduction Effects 0.000 title abstract description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 241000222336 Ganoderma Species 0.000 claims description 29
- 210000000582 semen Anatomy 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000002481 ethanol extraction Methods 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 28
- 206010013663 drug dependence Diseases 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 208000011117 substance-related disease Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 244000144730 Amygdalus persica Species 0.000 abstract description 3
- 244000042430 Rhodiola rosea Species 0.000 abstract description 3
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 2
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 2
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 2
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 2
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 2
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 2
- 240000008397 Ganoderma lucidum Species 0.000 abstract 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 2
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 2
- 235000021018 plums Nutrition 0.000 abstract 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 27
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- 238000000034 method Methods 0.000 description 11
- 108010028554 LDL Cholesterol Proteins 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000009427 jiangzhi Substances 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 230000007059 acute toxicity Effects 0.000 description 3
- 231100000403 acute toxicity Toxicity 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 231100001252 long-term toxicity Toxicity 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010039020 Rhabdomyolysis Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241001092040 Crataegus Species 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
病例 | 治疗 | 显效 | 有效 | 无效 | 恶化 |
总数 | 时间 | 例数 | 显效率 | 例数 | 有效率 | 例数 | 无效率 | 例数 | 恶化率 |
50 | 30天 | 21 | 46.25% | 21 | 41.25% | 8 | 12.5% | 0 | 0 |
50 | 61天 | 26 | 70% | 22 | 26.25% | 2 | 3.75% | 0 | 0 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510743094.6A CN105193993B (zh) | 2015-11-05 | 2015-11-05 | 一种具有降血脂功效的中药组合物及其制备方法与用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510743094.6A CN105193993B (zh) | 2015-11-05 | 2015-11-05 | 一种具有降血脂功效的中药组合物及其制备方法与用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105193993A true CN105193993A (zh) | 2015-12-30 |
CN105193993B CN105193993B (zh) | 2019-06-14 |
Family
ID=54942182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510743094.6A Active CN105193993B (zh) | 2015-11-05 | 2015-11-05 | 一种具有降血脂功效的中药组合物及其制备方法与用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105193993B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559162A (zh) * | 2021-08-02 | 2021-10-29 | 安徽九春堂药业有限公司 | 一种降低血脂的药物组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006036681A (ja) * | 2004-07-27 | 2006-02-09 | Hirose Yukihiro | 血液の中性脂肪の増加を抑制する作用を有する飲料 |
CN101873231A (zh) * | 2010-07-06 | 2010-10-27 | 联想网御科技(北京)有限公司 | 一种网络入侵特征配置方法及系统 |
-
2015
- 2015-11-05 CN CN201510743094.6A patent/CN105193993B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006036681A (ja) * | 2004-07-27 | 2006-02-09 | Hirose Yukihiro | 血液の中性脂肪の増加を抑制する作用を有する飲料 |
CN101873231A (zh) * | 2010-07-06 | 2010-10-27 | 联想网御科技(北京)有限公司 | 一种网络入侵特征配置方法及系统 |
Non-Patent Citations (2)
Title |
---|
云琦等: "新疆桃仁HPLC-UV指纹图谱研究及在地区分类中的应用", 《中国中药杂志》 * |
刘昆: "《本草纲目食物养生全书》", 31 October 2013 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559162A (zh) * | 2021-08-02 | 2021-10-29 | 安徽九春堂药业有限公司 | 一种降低血脂的药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105193993B (zh) | 2019-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145158A (zh) | 生姜与丁香组合物、其制备方法及其在制备癌症放、化疗中减毒增效药物中的用途 | |
CN103622019B (zh) | 一种降血脂、降尿酸中药组合物 | |
CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
CN112546167A (zh) | 一种具有健脾利湿功能的中药组合物及其制备方法和应用 | |
CN101243882B (zh) | 具有降血脂功能的保健食品及其制备方法 | |
CN107095995B (zh) | 一种治疗胃炎和胃溃疡的药物组合物及制备方法 | |
CN1558768A (zh) | 一种中药组合物及其制备方法 | |
CN107412713A (zh) | 治疗自体免疫性与免疫相关性疾病的中成药、医疗食品及制备方法 | |
CN103736071A (zh) | 一种具有辅助降血糖功效的组合物及其应用、制备方法 | |
CN105193993A (zh) | 一种具有降血脂功效的中药组合物及其制备方法与用途 | |
CN100509041C (zh) | 清胃排毒丸 | |
CN103720808B (zh) | 一种具有通便功效的组合物及其用途、制备方法 | |
CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
CN106038975A (zh) | 一种具有止咳作用的中药组合物及其制备方法与用途 | |
CN104721595B (zh) | 一种治疗高脂血症的中药组合物 | |
CN101926934B (zh) | 一种对胃粘膜和肝损伤有保护作用的药物及其制备方法 | |
CN103859393B (zh) | 一种食品及其制备方法和应用 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN102247572A (zh) | 一种治疗高脂血症的药物 | |
CN105194352A (zh) | 一种改善学习记忆的中药组合物及其制备方法 | |
CN105028750A (zh) | 中草药减肥茶及其制备方法 | |
CN106668704A (zh) | 回族中药参木胃癌散颗粒及其制备方法 | |
CN105641383A (zh) | 具有减肥作用的中药含片及其制备方法 | |
CN104547695B (zh) | 一种用于治疗三叉神经痛的药物组合物及其应用 | |
CN105709044A (zh) | 一种具有减肥作用的中药咀嚼片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240124 Address after: No. 77, Ring Road 2nd Lane, Gaopoxia Village, Chengxi Town, Longhua District, Haikou City, Hainan Province, 570216 Patentee after: Haikou Shanghe Biotechnology Co.,Ltd. Country or region after: China Address before: 571101 Institute of Tropical Biotechnology a503, No. 4 Xueyuan Road, Longhua District, Haikou City, Hainan Province Patentee before: INSTITUTE OF TROPICAL BIOSCIENCE AND BIOTECHNOLOGY, CHINESE ACADEMY OF TROPICAL AGRICULTURAL SCIENCES Country or region before: China |